Caris Life Sciences Release: Blood-Based Circulating Microvesicles (cMV) Data to be Presented at the 2013 International Society for Extracellular Vesicles (ISEV)
4/16/2013 11:23:22 AM
More...
|
Caris Life Sciences Symposium to Explore Advances in Next Generation Sequencing for Gynecologic Cancers
3/8/2013 9:34:16 AM
More...
|
Joachim Schorr, PhD, Named Chief Scientific Officer at Caris Life Sciences
3/5/2013 10:43:34 AM
More...
|
Caris Life Sciences Adds Next-Generation Sequencing to Enhance Evidence-Based Tumor Profiling Service for Cancer Patients
1/28/2013 10:28:50 AM
More...
|
Caris Life Sciences Sponsors CancerCare Connect Education Workshop on Molecular Profiling in the Treatment of Breast Cancer
12/6/2012 10:16:46 AM
More...
|
Caris Life Sciences Enhances Molecular Profiling Service With Addition of ROS1 and MGMT-Methylation Biomarkers
11/12/2012 11:25:43 AM
More...
|
Caris Life Sciences Selects Illumina, Inc. (ILMN)'s MiSeq® System to Enable Next-Generation Sequencing as Part of its Molecular Profiling Service
11/7/2012 9:40:45 AM
More...
|
Caris Life Sciences Launches Caris Target Now™ Select for NSCLC, Melanoma, and Cancers of the Breast, Colon, and Ovary
6/26/2012 10:23:01 AM
More...
|
Caris Life Sciences Target Now(TM) American Society of Clinical Oncology Presentations Underscore Importance of Molecular Profiling in Pancreatic Cancer and Uveal Melanoma
6/5/2012 10:29:13 AM
More...
|
Caris Life Sciences Announces Upcoming Launch of Caris Target Now Select(TM)
6/4/2012 12:07:20 PM
More...
|
|